State of Wyoming’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,984
Closed -$15K 1819
2022
Q3
$15K Sell
12,984
-6,452
-33% -$10.1K 0.01% 1397
2022
Q2
$35K Sell
19,436
-14,062
-42% -$20.7K 0.02% 1176
2022
Q1
$68K Buy
33,498
+8,079
+32% +$15.9K 0.03% 870
2021
Q4
$69K Buy
25,419
+13,614
+115% +$50.3K 0.03% 914
2021
Q3
$53K Sell
11,805
-237
-2% -$1.14K 0.03% 745
2021
Q2
$70K Buy
+12,042
New +$70.6K 0.04% 609

Other funds holding CLVS

State of Wyoming's CLVS Position: Q4 2022 in Review

State of Wyoming sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 12,984 shares — an estimated $15K sold.

State of Wyoming first reported a position in CLVS in Q2 2021 and held it in 6 quarters. The position peaked at $70K in Q2 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • State of Wyoming reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • State of Wyoming sold 12,984 Clovis Oncology, Inc. shares in Q4 2022, an estimated $15K.
  • State of Wyoming first reported a position in Clovis Oncology, Inc. in Q2 2021 and held it in 6 quarters.
  • State of Wyoming's Clovis Oncology, Inc. position peaked at $70K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on State of Wyoming's 13F filing for Q4 2022, filed 15 Feb 2023.